MAIA PE Ratio & Valuation,Is MAIA Overvalued

MAIA Relative Valuation

MAIA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MAIA is overvalued; if below, it's undervalued.

Historical Valuation

Maia Biotechnology Inc (MAIA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.50. The fair price of Maia Biotechnology Inc (MAIA) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：1.34

Fair

-1.96

-1.24

EV/EBITDA

Maia Biotechnology Inc. (MAIA) has a current EV/EBITDA of -1.24. The 5-year average EV/EBITDA is -1.30. The thresholds are as follows: Strongly Undervalued below -2.36, Undervalued between -2.36 and -1.83, Fairly Valued between -0.77 and -1.83, Overvalued between -0.77 and -0.24, and Strongly Overvalued above -0.24. The current Forward EV/EBITDA of -1.24 falls within the Historic Trend Line -Fairly Valued range.

-1.27

EV/EBIT

Maia Biotechnology Inc. (MAIA) has a current EV/EBIT of -1.27. The 5-year average EV/EBIT is -1.23. The thresholds are as follows: Strongly Undervalued below -2.22, Undervalued between -2.22 and -1.73, Fairly Valued between -0.74 and -1.73, Overvalued between -0.74 and -0.24, and Strongly Overvalued above -0.24. The current Forward EV/EBIT of -1.27 falls within the Historic Trend Line -Fairly Valued range.

0.00

Maia Biotechnology Inc. (MAIA) has a current PS of 0.00. The 5-year average PS is 1.40. The thresholds are as follows: Strongly Undervalued below -5.11, Undervalued between -5.11 and -1.85, Fairly Valued between 4.66 and -1.85, Overvalued between 4.66 and 7.92, and Strongly Overvalued above 7.92. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Maia Biotechnology Inc. (MAIA) has a current P/OCF of 0.00. The 5-year average P/OCF is -0.58. The thresholds are as follows: Strongly Undervalued below -2.18, Undervalued between -2.18 and -1.38, Fairly Valued between 0.23 and -1.38, Overvalued between 0.23 and 1.03, and Strongly Overvalued above 1.03. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Maia Biotechnology Inc. (MAIA) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Maia Biotechnology Inc (MAIA) has a current Price-to-Book (P/B) ratio of 1129.03. Compared to its 3-year average P/B ratio of 91.25 , the current P/B ratio is approximately 1137.32% higher. Relative to its 5-year average P/B ratio of 80.99, the current P/B ratio is about 1294.07% higher. Maia Biotechnology Inc (MAIA) has a Forward Free Cash Flow (FCF) yield of approximately -31.24%. Compared to its 3-year average FCF yield of -34.73%, the current FCF yield is approximately -10.05% lower. Relative to its 5-year average FCF yield of -33.40% , the current FCF yield is about -6.46% lower.

1116.63

P/B

Median3y

91.25

Median5y

80.99

-31.24

FCF Yield

Median3y

-34.73

Median5y

-33.40

Competitors Valuation Multiple

The average P/S ratio for MAIA's competitors is 0.00, providing a benchmark for relative valuation. Maia Biotechnology Inc Corp (MAIA) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of MAIA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of MAIA in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is Maia Biotechnology Inc (MAIA) currently overvalued or undervalued?

What is Maia Biotechnology Inc (MAIA) fair value?

MAIA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Maia Biotechnology Inc (MAIA) is between NaN to NaN according to relative valuation methord.

How does MAIA's valuation metrics compare to the industry average?

What is the current P/B ratio for Maia Biotechnology Inc (MAIA) as of Dec 16 2025?

As of Dec 16 2025, Maia Biotechnology Inc (MAIA) has a P/B ratio of 1129.03. This indicates that the market values MAIA at 1129.03 times its book value.

What is the current FCF Yield for Maia Biotechnology Inc (MAIA) as of Dec 16 2025?

As of Dec 16 2025, Maia Biotechnology Inc (MAIA) has a FCF Yield of -31.24%. This means that for every dollar of Maia Biotechnology Inc’s market capitalization, the company generates -31.24 cents in free cash flow.

What is the current Forward P/E ratio for Maia Biotechnology Inc (MAIA) as of Dec 16 2025?

As of Dec 16 2025, Maia Biotechnology Inc (MAIA) has a Forward P/E ratio of -1.98. This means the market is willing to pay $-1.98 for every dollar of Maia Biotechnology Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Maia Biotechnology Inc (MAIA) as of Dec 16 2025?

As of Dec 16 2025, Maia Biotechnology Inc (MAIA) has a Forward P/S ratio of 0.00. This means the market is valuing MAIA at $0.00 for every dollar of expected revenue over the next 12 months.

MAIA Valuation

MAIA Valuation

MAIA Relative Valuation

Historical Valuation

Competitors Valuation Multiple

Performance Decomposition

People Also Watch

Frequently Asked Questions

Is Maia Biotechnology Inc (MAIA) currently overvalued or undervalued?

What is Maia Biotechnology Inc (MAIA) fair value?

How does MAIA's valuation metrics compare to the industry average?

What is the current P/B ratio for Maia Biotechnology Inc (MAIA) as of Dec 16 2025?

What is the current FCF Yield for Maia Biotechnology Inc (MAIA) as of Dec 16 2025?

What is the current Forward P/E ratio for Maia Biotechnology Inc (MAIA) as of Dec 16 2025?

What is the current Forward P/S ratio for Maia Biotechnology Inc (MAIA) as of Dec 16 2025?